The Pandemic Stress Vaccine: A Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak

This study has been terminated.

(low participation and retention rates)

Sponsor:

Information provided by:

Mount Sinai Hospital, Canada

ClinicalTrials.gov Identifier:

NCT00962273

First received: August 18, 2009

Last updated: August 17, 2010

Last verified: August 2010

History of Changes

Purpose

The purpose of this study is to determine the effects of an interactive, computerized learning resource designed to increase resilience in hospital-based health care workers preparing for an influenza pandemic. The effects of the learning resource will be compared to a non-interactive learning resource condition and a control condition. It is hypothesized that (a) online pandemic-related education reduces absenteeism and interpersonal problems for healthcare workers (HCWs), and improves their pandemic self-efficacy in the short and long-term, and (b) an interactive format for online education is necessary for its benefits.

Condition	Intervention
Psychological Stress	Behavioral: Interactive computerized learning resource Behavioral: Didactic computerized learning resource

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Investigator) Primary Purpose: Health Services Research
Official Title:	The Pandemic Stress Vaccine: Randomized Controlled Trial of an Educational Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak

Resource links provided by NLM:

MedlinePlus related topics: Disaster Preparation and Recovery Stress

U.S. FDA Resources

Further study details as provided by Mount Sinai Hospital, Canada:

Primary Outcome Measures:

Absenteeism [ Time Frame: 32 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Pandemic self-efficacy [ Time Frame: 32 weeks ] [ Designated as safety issue: No ]
Interpersonal problems [ Time Frame: 32 weeks ] [ Designated as safety issue: No ]

Enrollment:	118
Study Start Date:	October 2009
Study Completion Date:	July 2010
Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Pandemic Stress Vaccine - Interactive	Behavioral: Interactive computerized learning resource In a series of interactive scenarios, participants can "see" themselves in stressful work situations that could arise during an influenza pandemic and reflect on effective ways to work out personal and interpersonal difficulties.
Active Comparator: Pandemic Stress Vaccine - Didactic	Behavioral: Didactic computerized learning resource In a non-interactive format (i.e., a series of audio presentations with accompanying PowerPoint-type slides) participants are given information on how to handle stressful work situations that could arise during an influenza pandemic.
No Intervention: Wait list Some participants are assigned to an eight week waiting condition prior to the course commencing.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

employee or professional staff of a hospital

Exclusion Criteria:

unable to read and write English

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00962273

Locations

Canada, Ontario
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5

Sponsors and Collaborators

Mount Sinai Hospital, Canada

Investigators

Principal Investigator:	William J. Lancee, Ph.D.	Mount Sinai Hospital, New York
Principal Investigator:	Robert G. Maunder, M.D.	Mount Sinai Hospital, New York

More Information

Publications:

Maunder RG, Lancee WJ, Balderson KE, Bennett JP, Borgundvaag B, Evans S, Fernandes CM, Goldbloom DS, Gupta M, Hunter JJ, McGillis Hall L, Nagle LM, Pain C, Peczeniuk SS, Raymond G, Read N, Rourke SB, Steinberg RJ, Stewart TE, VanDeVelde-Coke S, Veldhorst GG, Wasylenki DA. Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak. Emerg Infect Dis. 2006 Dec;12(12):1924-32.

Responsible Party:	Dr. William Lancee - Head of Research, Department of Psychiatry, Mount Sinai Hospital
ClinicalTrials.gov Identifier:	NCT00962273 History of Changes
Other Study ID Numbers:	09-0133-E
Study First Received:	August 18, 2009
Last Updated:	August 17, 2010
Health Authority:	Canada: Ethics Review Committee

Keywords provided by Mount Sinai Hospital, Canada:

health personnel
communicable diseases
stress, psychological
resilience, psychological

disaster planning
education
online

Additional relevant MeSH terms:

Stress, Psychological
Behavioral Symptoms

ClinicalTrials.gov processed this record on May 21, 2013

To Top